Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Selbyville, Delaware, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The biopsy needle market value is poised to surpass USD 2.2 billion by 2032, according to a new research report by Global Market Insights...
-
PHOENIX, Jan. 25, 2023 (GLOBE NEWSWIRE) -- RAADR, Inc. (OTC PINK: RDAR), a technology and software development company that provides cutting edge solutions to detect and combat cyber-bullying and...
-
HERZLIYA, Israel, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Namogoo, the world's first Digital Journey Continuity platform, has integrated with Google Cloud to add new layers to the customer journey that...
-
Concord, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Concord, North Carolina - C.A.S.E. Discount Flooring, headquartered in Concord, NC, is offering a wide selection of Luxury Vinyl Plank (LVP) flooring...
-
WEST DES MOINES, Iowa and IPSWICH, United Kingdom, Jan. 25, 2023 (GLOBE NEWSWIRE) -- ITA Group, a global leader in corporate engagement solutions, has announced its acquisition of HTK Limited, a...
-
Portland, Ore., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Act-On Software has earned HIPAA compliance, adding to the marketing automation platform’s robust information security standards. This compliance...
-
WASHINGTON, Jan. 25, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced it...
-
Washington, D.C., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Foundation for Financial Planning (FFP), a 501(c)(3) nonprofit organization dedicated to expanding access to pro bono financial planning for...
-
SUNNYVALE, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Matterport, Inc. (Nasdaq: MTTR) today released the company’s first Environmental, Social, and Governance (ESG) report that assesses the impact of...
-
Positive top-line results from Phase IIa trial of SPL026 in Major Depressive Disorder New SPL026 trials underway and screening commenced in the first in-human study of SPL028 LONDON, Jan. 25,...